Molecular optical imaging of therapeutic targets of cancer

Area of Science:

• Oncology
• Molecular Imaging
• Nanotechnology

Background:

• Molecular-targeted cancer therapies offer improved efficacy and reduced toxicity compared to conventional treatments.
• Current methods for visualizing molecular markers in tumors are primarily in vitro and lack dynamic, in vivo capabilities.
• Effective utilization of molecular-targeted therapy necessitates advanced tools for real-time monitoring of tumor heterogeneity.

Purpose of the Study:

• To discuss emerging optical tools for in vivo molecular imaging of cancer hallmarks.
• To enable dynamic and quantitative monitoring of heterogeneous tumor molecular profiles during therapy.
• To facilitate selection and monitoring of molecular-targeted cancer therapies.

Main Methods:

• Integration of optically active, targeted nanoparticles for molecular imaging.
• Advancements in minimally invasive optical imaging systems.
• Dynamic in vivo imaging of molecular and phenotypic risk profiles.

Main Results:

• The proposed approach allows for in vivo visualization of molecular markers.
• Enables dynamic monitoring of both molecular and phenotypic tumor characteristics.
• Facilitates tracking of treatment-induced changes in tumor profiles.

Conclusions:

• Emerging optical tools, combining targeted nanoparticles and advanced imaging, show promise for in vivo cancer molecular profiling.
• These tools can dynamically monitor tumor heterogeneity and response to therapy.
• This approach supports personalized cancer treatment selection and monitoring.